Phylogenies reveal predictive power of traditional medicine in bioprospecting
- 10 September 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (39), 15835-15840
- https://doi.org/10.1073/pnas.1202242109
Abstract
There is controversy about whether traditional medicine can guide drug discovery, and investment in bioprospecting informed by ethnobotanical data has fluctuated. One view is that traditionally used medicinal plants are not necessarily efficacious and there are no robust methods for distinguishing those which are most likely to be bioactive when selecting species for further testing. Here, we reconstruct a genus-level molecular phylogenetic tree representing the 20,000 species found in the floras of three disparate biodiversity hotspots: Nepal, New Zealand, and the Cape of South Africa. Borrowing phylogenetic methods from community ecology, we reveal significant clustering of the 1,500 traditionally used species, and provide a direct measure of the relatedness of the three medicinal floras. We demonstrate shared phylogenetic patterns across the floras: related plants from these regions are used to treat medical conditions in the same therapeutic areas. This finding strongly indicates independent discovery of plant efficacy, an interpretation corroborated by the presence of a significantly greater proportion of known bioactive species in these plant groups than in random samples. We conclude that phylogenetic cross-cultural comparisons can focus screening efforts on a subset of traditionally used plants that are richer in bioactive compounds, and could revitalize the use of traditional knowledge in bioprospecting.Keywords
This publication has 49 references indexed in Scilit:
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liverProceedings of the National Academy of Sciences of the United States of America, 2012
- Clustered patterns of species origins of nature-derived drugs and clues for future bioprospectingProceedings of the National Academy of Sciences of the United States of America, 2011
- Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sourcesPharmacology & Therapeutics, 2009
- A Rapid Bootstrap Algorithm for the RAxML Web ServersSystematic Biology, 2008
- Natural products in drug discoveryDrug Discovery Today, 2008
- Ethnobotanical knowledge is associated with indices of child health in the Bolivian AmazonProceedings of the National Academy of Sciences of the United States of America, 2007
- Herbal Medicine Today: Clinical and Research IssuesEvidence-Based Complementary and Alternative Medicine, 2007
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Conservation evaluation and phylogenetic diversityBiological Conservation, 1992